FoxWayne Enterprises Acquisition Corp. (NASDAQ:FOXW) announced this afternoon that it has agreed to mutually terminate its combination with biopharmaceutical company Aerami Therapeutics.
Similar to other recent SPAC terminations, FoxWayne has also stated that it will be terminating its combination due to unfavorable market conditions. The SPAC’s current extended deadline is April 22, 2022, but FoxWayne can extend an additional three months to July 22, 2022 by contributing $0.025 per share to trust. That gives this SPAC roughly 4.6 months left to complete a business combination, assuming they extend.
The FoxWayne/Aerami deal marks the ninth intended SPAC combination to terminate in 2022 year-to-date, and the third in the biotech/healthcare sector, which as a sector has been struggling. However, on average, those nine terminated deals still have 9.6 months of life left to find another combination and complete.
FoxWayne originally priced a $50 million IPO last January and intends to focus on combining with a biotechnology or telemedicine business in North America that will be resilient to economic cycles. The company is led by Chairman, CEO and CFO Robb Knie.
The SPAC originally announced its combination with Aerami a few months ago in the beginning of December. Durham, North Carolina-based Aerami is developing a series of inhaled therapies for severe respiratory diseases and inhaled insulin solutions.
At the SPAC of Dawn Space has been one of the most promising sectors for SPAC deals in recent years with four of the 14 de-SPACs that closed deals dating back to 2019 now trading above $10 and two of these above $20. A new company is about to test the traditional route to market,...
Quantumsphere (NASDAQ:QUMSU) has filed for a $60 million IPO with a team that has been steadily increasing its experience in SPACs through ties to several others in the Announced and Searching columns. The new SPAC is the second smallest that filed its first S-1 in the month of May and comes after 14-straight filings for...
At the SPAC of Dawn Futures remain slightly red ever since the OECD downgraded global growth forecasts in light of the ongoing tariff disputes. This impact is anticipated to be felt most strongly in the US and Japan, although the later is expected to begin a rebound in 2026. This organization does not include African...
Crown Reserve Acquisition Corp. I (NASDAQ:CRACU) has filed for a $150 million IPO to seek out a biotech deal with a team tied to one of the busiest names in SPACs recently. The new SPAC was filed as something of a pair with Quantumsphere Acquisition Corporation (NASDAQ:QUMSU), which was also underwritten by SPAC Advisory Partners...
FG Merger III Corp. has filed for a $150 million IPO to continue with the FG serial SPAC family with a larger vehicle focused on the financial services industry. The new SPAC is one of 16 SPACs that were filed in May and one of the four that overfunded its trust. FG Merger III is...